Company news
Cisen Pharmaceutical Ltd. news in 2026
Cisen Pharmaceutical Ltd.'s news releases, calls and decks from 2026, newest first.
(603367)"Cisen Pharmaceutical Co., Ltd."Report for Q3 2026
October 27, 2026
(603367)"Cisen Pharmaceutical Co., Ltd."Announcement on Resolutions of the 15th Meeting of the 5th Board of Directors
October 27, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 22, 2026
Announcement on a Subsidiary's Receipt of the First Generic Approval for Marketing of Its Loteprednol Etabonate and Tobramycin Eye Drops
September 14, 2026
Announcement on Implementation of Dividend Distribution for the First Half of 2026
September 7, 2026
Announcement on Outline of the 2026 Semi-annual Performance and Cash Dividend Briefing
September 2, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
August 24, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 27, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
May 12, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 7, 2026
Report for Q1 2026
April 28, 2026
Announcement on Completion of Shareholding Reduction Plan for Shareholders and Results of Shareholding Reduction
April 15, 2026
Announcement on Outline of the 2025 Annual Performance and Cash Dividend Briefing
April 13, 2026
Announcement on 2025 Annual Profit Distribution Plan
April 2, 2026
Announcement on Shareholding Reduction Plan for Shareholders
March 13, 2026
Announcement on Changing Sponsor Representative
February 10, 2026
Announcement on Release of Pledge of Shareholder's Shares
January 8, 2026
Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management and Securities Investment by the Company and its Holding Subsidiary
January 5, 2026